Cervical Cancer Vaccine Gardasil Is Cost-Effective, To A Point

August 23, 2008

Harvard researchers have put out a new study which shows that the cervical cancer vaccine Gardasil is very cost-effetive up to a certain age......Washington (ChattahBox) – Harvard researchers have put out a new study which shows that the cervical cancer vaccine Gardasil is very cost-effective up to a certain age.

For their study, Harvard researchers looked over just how cost-effective the cervical cancer vaccine Gardasil was.

The cervical cancer vaccine Gardasil was first approved in 2006, and was recommended by the CDC for all girls aged 11 and 12-years old.

It protects against two strains of HPV, which lead to 70% of all cervical cancer cases.

Researchers stated that Gardasil is most cost-effective if you can use the vaccine on all 12-year old girls, and the immunize women under the age of 12.

Once women are over the age of 21 though, it begins to become less cost-effective. The three doses of Gardasil cost around $350.

Their study has been published in the August 21 issue of the New England Journal of Medicine.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.